Literature DB >> 3368939

Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors.

S Kleinman1, L Fitzpatrick, K Secord, D Wilke.   

Abstract

We conducted anti-HIV testing on follow-up samples obtained at a mean interval of 20 weeks from 150 blood donors who had previously tested anti-HIV ELISA positive and Western blot atypical. Of 93 donors who demonstrated reactivity to HIV core protein p24, 4 progressed to positive Western blots. Most of the remaining donors showed a persistent p24 reactivity on Western blot and had no risk factors for HIV infection. Immunofluorescence testing of the initial sample from 93 donors could not definitively separate seroconverters from those with persistent p24 reactivity. Of 57 donors with p18 reactivity, none were positive on follow-up anti-HIV testing. Our findings suggest policies and strategies for notifying donors of atypical anti-HIV Western blot results.

Entities:  

Mesh:

Year:  1988        PMID: 3368939     DOI: 10.1046/j.1537-2995.1988.28388219161.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1.

Authors:  E Ramirez; P Uribe; D Escanilla; G Sanchez; R T Espejo
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Evaluation of rapid prenatal human immunodeficiency virus testing in rural cameroon.

Authors:  Timothy C Granade; Bharat S Parekh; Pius M Tih; Thomas Welty; Edith Welty; Marc Bulterys; George Ndikintum; Godlove Nkuoh; Samuel Tancho
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 4.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

5.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosis.

Authors:  J C Lallement; J P Vendrell; P Corbeau; J Ducos; M Segondy; A Escande; V Robert-Hebmann; F Jean; J Reynes; A Serre
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays.

Authors:  B Weber; E H Fall; A Berger; H W Doerr
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

8.  Divergent HIV and simian immunodeficiency virus surveillance, Zaire.

Authors:  Amanda Schaefer; Kenneth E Robbins; Eugene Nzila Nzilambi; Michael E St Louis; Thomas C Quinn; Thomas M Folks; Marcia L Kalish; Danuta Pieniazek
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.